ELISA Kit for Gastrin (GT)
GAST; GAS; Gastrin component I; Big gastrin; Gastrin component II; Gastrin component III
- Product No.CEB224Mu
- Organism SpeciesMus musculus (Mouse)Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range12.35-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 4.81pg/mL.
- DownloadInstruction Manual
Ensure in stock; if not, free redo!
- FOB US$ 479
For negotiated price and more details, please contact local distributors! US$ 684
For negotiated price and more details, please contact local distributors! US$ 3078
For negotiated price and more details, please contact local distributors! US$ 5814
For negotiated price and more details, please contact local distributors! US$ 47880
For negotiated price and more details, please contact local distributors!
This assay has high sensitivity and excellent specificity for detection of Gastrin (GT).
No significant cross-reactivity or interference between Gastrin (GT) and analogues was observed.
Matrices listed below were spiked with certain level of recombinant Gastrin (GT) and the recovery rates were calculated by comparing the measured value to the expected amount of Gastrin (GT) in samples.
|Matrix||Recovery range (%)||Average(%)|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Gastrin (GT) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Gastrin (GT) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Gastrin (GT) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
|Pre-coated, ready to use 96-well strip plate||1||Plate sealer for 96 wells||4|
|Detection Reagent A||1×120µL||Assay Diluent A||1×12mL|
|Detection Reagent B||1×120µL||Assay Diluent B||1×12mL|
|TMB Substrate||1×9mL||Stop Solution||1×6mL|
|Wash Buffer (30 × concentrate)||1×20mL||Instruction manual||1|
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Gastrin (GT) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Gastrin (GT) and unlabeled Gastrin (GT) (Standards or samples) with the pre-coated antibody specific to Gastrin (GT). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Gastrin (GT) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Gastrin (GT) in the sample.
|Cell reports||Liver-Derived Systemic Factors Drive b Cell Hyperplasia in Insulin-Resistant StatesPubMed: PMC3655439|
|Journal of Pharmacy and Pharmacology||Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjectsPubmed: 24628303|
|Pharmacological Reports||Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic micePubmed: 24145087|
|Nanoscale||Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptiveproperty for the treatment of Helicobacter pylori infection.pubmed:27605059|
|Catalog No.||Related products for research use of Mus musculus (Mouse) Organism species||Applications|
|RPB224Mu01||Recombinant Gastrin (GT)||Positive Control; Immunogen; SDS-PAGE; WB.|
|RPB224Mu02||Recombinant Gastrin (GT)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAB224Mu02||Polyclonal Antibody to Gastrin (GT)||WB; IHC; ICC; IP.|
|PAB224Mu01||Polyclonal Antibody to Gastrin (GT)||WB; IHC; ICC; IP.|
|LAB224Mu81||FITC-Linked Polyclonal Antibody to Gastrin (GT)||WB; IHC; ICC; IF.|
|LAB224Mu71||Biotin-Linked Polyclonal Antibody to Gastrin (GT)||WB; IHC; ICC.|
|CEB224Mu||ELISA Kit for Gastrin (GT)||Enzyme-linked immunosorbent assay for Antigen Detection.|